<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus genome-positive Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> is endemic in Africa and Papua New Guinea and in both countries the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> is restricted to regions with holoendemic <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The present work has compared groups of healthy indigenous individuals living in malarious and non-malarious regions of Papua New Guinea for Epstein-Barr virus-specific T-cell-mediated immunity using the in vitro regression assay </plain></SENT>
<SENT sid="2" pm="."><plain>Residents of the malarious region (55 tested), when compared with either residents of the non-malarious area (35 tested) or Caucasian controls (27 tested) showed a significant (p less than 0.0001) impairment of virus-specific T-cell immunity but no obvious disturbance (p greater than 0.05) of anti-<z:mp ids='MP_0001799'>viral</z:mp> antibody titres </plain></SENT>
<SENT sid="3" pm="."><plain>These results may be important in explaining the postulated role of malarial <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> as a co-factor in the pathogenesis of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
</text></document>